BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 187943)

  • 21. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 22. Nontolerance to the opioid antagonism of naltrexone.
    Kleber HD; Kosten TR; Gaspari J; Topazian M
    Biol Psychiatry; 1985 Jan; 20(1):66-72. PubMed ID: 2981129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy.
    Callahan E; Rawson R; Glazer M; McCleave B; Arias R
    NIDA Res Monogr; 1976 Sep; (9):150-7. PubMed ID: 794716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
    Altman JL; Meyer RE; Mirin SM; McNamee HB
    Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
    Lewis DC
    Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
    [No Abstract]   [Full Text] [Related]  

  • 26. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
    Resnick RB; Schuyten-Resnick E; Washton AM
    Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
    [No Abstract]   [Full Text] [Related]  

  • 27. Limitations of an extinction approach to narcotic antagonist treatment.
    Meyer R; Randall R; Barrington C; Mirin S; Greenberg I
    NIDA Res Monogr; 1976 Sep; (9):123-35. PubMed ID: 187940
    [No Abstract]   [Full Text] [Related]  

  • 28. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 29. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison.
    Judson BA; Carney TM; Goldstein A
    Drug Alcohol Depend; 1981 Jul; 7(4):325-46. PubMed ID: 7023894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of narcotic antagonists.
    O'Brien CP; Greenstein R; Ternes J; Woody GE
    Ann N Y Acad Sci; 1978; 311():232-40. PubMed ID: 369432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone study guidelines: good vehicle--wrong destination.
    Brahen LS
    Am J Drug Alcohol Abuse; 1975; 2(3-4):451-3. PubMed ID: 1227303
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM; Glass WJ
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experiences with naltrexone in 370 detoxified addicts.
    Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
    NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies.
    Schecter AJ; Friedman JG; Grossman DJ
    Am J Drug Alcohol Abuse; 1974; 1(2):253-69. PubMed ID: 4467728
    [No Abstract]   [Full Text] [Related]  

  • 36. Naltrexone: the clinical investigator's dilemma.
    Ling W
    NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297
    [No Abstract]   [Full Text] [Related]  

  • 37. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of heroin dependence with naltrexone.
    Martin WR
    Curr Psychiatr Ther; 1975; 15():157-61. PubMed ID: 1181122
    [No Abstract]   [Full Text] [Related]  

  • 39. Historical trends in naltrexone research.
    Julius DA
    NIDA Res Monogr; 1978; (19):301-7. PubMed ID: 106296
    [No Abstract]   [Full Text] [Related]  

  • 40. Historical perspective on the chemistry and development of naltrexone.
    Archer S
    NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.